[Therapy of multiple myeloma. What is confirmed?].

about

[Therapy of multiple myeloma. What is confirmed?].

Item

http://www.wikidata.org/entity/Q54646139

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

[Therapy of multiple myeloma. What is confirmed?].

@en

[Therapy of multiple myeloma. What is confirmed?].

@nl

type

Item

label

[Therapy of multiple myeloma. What is confirmed?].

@en

[Therapy of multiple myeloma. What is confirmed?].

@nl

prefLabel

[Therapy of multiple myeloma. What is confirmed?].

@en

[Therapy of multiple myeloma. What is confirmed?].

@nl

P1476

[Therapy of multiple myeloma. What is confirmed?].

@en

P2093

A Ganser

http://www.w3.org/2001/XMLSchema#string

D Peest

http://www.w3.org/2001/XMLSchema#string

H Einsele

http://www.w3.org/2001/XMLSchema#string

P2860

First-line tandem high-dose chemotherapy and autologous stem cell transplantation versus single high-dose chemotherapy and autologous stem cell transplantation in multiple myeloma, a systematic review of controlled studies

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management.

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma.

Prevalence of monoclonal gammopathy of undetermined significance.

Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma.

IMWG consensus on maintenance therapy in multiple myeloma.

Improved survival in multiple myeloma and the impact of novel therapies.

International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease.

P304

1434, 1436-8, 1440-2

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00108-013-3323-7

http://www.w3.org/2001/XMLSchema#string

P407

Af-Jarmal

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24201762

http://www.w3.org/2001/XMLSchema#string